Robert F. Kennedy, Jr., declared chronic diseases an “existential threat.” Then his agency terminated one of the world’s ...

The U.S. Diabetes Prevention Program, or DPP, reported on April 28 the 21-year follow-up of a randomized clinical trial, ...

Type 2 diabetes can increase your risk of pancreatic cancer, but the amount of time since your diagnosis can affect your risk ...

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...

Researchers conducted a target trial emulation to compare the effects of SGLT-2 inhibitor and DPP-4 inhibitor use on epilepsy among patients with type 2 diabetes.

High Muscle Strength Linked to Lower Risk of Type 2 Diabetes Apr. 8, 2025 — Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle ...

In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk for falls, and combined use with GLP-1 RAs nearly tripled the risk.

Carnegie Mellon researchers have used FRESH 3D bioprinting to create the first collagen-based microphysiologic systems, ...

Gut microbes in early life play a key role in shaping insulin production and diabetes risk, with Candida dubliniensis showing ...

The study retrospectively identified published ... Comorbidities of interest were diabetes and tobacco smoking, both of which have been linked to skin infection in minor skin procedures, as ...

Some of the most popular supplements used for diabetes include: Researchers rarely study supplements and aren’t required to prove any claims. The safety and efficacy of supplements are generally ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.